4D Molecular Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $566.7M
Liabilities Breakdown FY2025
Total Liabilities: $61.0M
Asset Breakdown
Total Assets: $566.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $60.2M | 10.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $14.9M | 2.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $491.6M | 86.7% |
Liabilities Breakdown
Total Liabilities: $61.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.2M | 18.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $49.9M | 81.7% |